SU‐FF‐T‐613

Evaluation of Changes in Dose Distribution Caused by Weight Loss Using Megavoltage CT

S. Park, Myonggeun Yoon, D. Shin, Y. Lim, D. Kim, S. Lee, S. Park, K. Cheong, S. Kang, K. Kim, H. Bae

Research output: Contribution to journalArticle

Abstract

Purpose: Weight loss is a factor necessitating re‐planning to ensure that prescribed doses are delivered. Daily imaging during RT is useful to reduce uncertainties in the shapes and positions of tumors and healthy tissues. We studied the main characteristics of weight‐loss induced dose changes during tomotherapy treatment, based on an analysis of dose‐volume histograms. Method and Materials: Four head‐and‐neck cancer patients were scanned in a supine position and a target contour was delineated for each patient using a tomotherapy treatment planning system. To quantify weight‐loss induced dose changes, thermoluminescent dosimeter (TLD) measurements were also performed under conditions of changing bolus thickness, which were considered to simulate weight loss. Results: The results showed that weight loss results not only in target dose reductions but also affects tumor hot spots. Although the average minimum dose to the gross tumor volume in the four patients decreased from 91.9% to 86.7% of the prescription dose, the average maximum dose increased from 109.0% to 112.4% of the prescription dose. This suggests that weight loss‐induced cold spots and hot spots may result in significant dose inhomogeneity, which might be related to clinical outcome. Conclusion: Attention should be paid to weight loss during tomotherapy treatment and an adaptive plan should be considered to achieve prescribed doses to targets and to spare nearby critical structures if a patient shows significant weight loss.

Original languageEnglish
Pages (from-to)2665-2666
Number of pages2
JournalMedical Physics
Volume36
Issue number6
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Weight Loss
Prescriptions
Neoplasms
Supine Position
Tumor Burden
Uncertainty
Therapeutics
Weights and Measures

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐FF‐T‐613 : Evaluation of Changes in Dose Distribution Caused by Weight Loss Using Megavoltage CT. / Park, S.; Yoon, Myonggeun; Shin, D.; Lim, Y.; Kim, D.; Lee, S.; Park, S.; Cheong, K.; Kang, S.; Kim, K.; Bae, H.

In: Medical Physics, Vol. 36, No. 6, 2009, p. 2665-2666.

Research output: Contribution to journalArticle

Park, S, Yoon, M, Shin, D, Lim, Y, Kim, D, Lee, S, Park, S, Cheong, K, Kang, S, Kim, K & Bae, H 2009, 'SU‐FF‐T‐613: Evaluation of Changes in Dose Distribution Caused by Weight Loss Using Megavoltage CT', Medical Physics, vol. 36, no. 6, pp. 2665-2666. https://doi.org/10.1118/1.3182111
Park, S. ; Yoon, Myonggeun ; Shin, D. ; Lim, Y. ; Kim, D. ; Lee, S. ; Park, S. ; Cheong, K. ; Kang, S. ; Kim, K. ; Bae, H. / SU‐FF‐T‐613 : Evaluation of Changes in Dose Distribution Caused by Weight Loss Using Megavoltage CT. In: Medical Physics. 2009 ; Vol. 36, No. 6. pp. 2665-2666.
@article{29ae20c534dd4bceb71dfa3613dddb3d,
title = "SU‐FF‐T‐613: Evaluation of Changes in Dose Distribution Caused by Weight Loss Using Megavoltage CT",
abstract = "Purpose: Weight loss is a factor necessitating re‐planning to ensure that prescribed doses are delivered. Daily imaging during RT is useful to reduce uncertainties in the shapes and positions of tumors and healthy tissues. We studied the main characteristics of weight‐loss induced dose changes during tomotherapy treatment, based on an analysis of dose‐volume histograms. Method and Materials: Four head‐and‐neck cancer patients were scanned in a supine position and a target contour was delineated for each patient using a tomotherapy treatment planning system. To quantify weight‐loss induced dose changes, thermoluminescent dosimeter (TLD) measurements were also performed under conditions of changing bolus thickness, which were considered to simulate weight loss. Results: The results showed that weight loss results not only in target dose reductions but also affects tumor hot spots. Although the average minimum dose to the gross tumor volume in the four patients decreased from 91.9{\%} to 86.7{\%} of the prescription dose, the average maximum dose increased from 109.0{\%} to 112.4{\%} of the prescription dose. This suggests that weight loss‐induced cold spots and hot spots may result in significant dose inhomogeneity, which might be related to clinical outcome. Conclusion: Attention should be paid to weight loss during tomotherapy treatment and an adaptive plan should be considered to achieve prescribed doses to targets and to spare nearby critical structures if a patient shows significant weight loss.",
author = "S. Park and Myonggeun Yoon and D. Shin and Y. Lim and D. Kim and S. Lee and S. Park and K. Cheong and S. Kang and K. Kim and H. Bae",
year = "2009",
doi = "10.1118/1.3182111",
language = "English",
volume = "36",
pages = "2665--2666",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐FF‐T‐613

T2 - Evaluation of Changes in Dose Distribution Caused by Weight Loss Using Megavoltage CT

AU - Park, S.

AU - Yoon, Myonggeun

AU - Shin, D.

AU - Lim, Y.

AU - Kim, D.

AU - Lee, S.

AU - Park, S.

AU - Cheong, K.

AU - Kang, S.

AU - Kim, K.

AU - Bae, H.

PY - 2009

Y1 - 2009

N2 - Purpose: Weight loss is a factor necessitating re‐planning to ensure that prescribed doses are delivered. Daily imaging during RT is useful to reduce uncertainties in the shapes and positions of tumors and healthy tissues. We studied the main characteristics of weight‐loss induced dose changes during tomotherapy treatment, based on an analysis of dose‐volume histograms. Method and Materials: Four head‐and‐neck cancer patients were scanned in a supine position and a target contour was delineated for each patient using a tomotherapy treatment planning system. To quantify weight‐loss induced dose changes, thermoluminescent dosimeter (TLD) measurements were also performed under conditions of changing bolus thickness, which were considered to simulate weight loss. Results: The results showed that weight loss results not only in target dose reductions but also affects tumor hot spots. Although the average minimum dose to the gross tumor volume in the four patients decreased from 91.9% to 86.7% of the prescription dose, the average maximum dose increased from 109.0% to 112.4% of the prescription dose. This suggests that weight loss‐induced cold spots and hot spots may result in significant dose inhomogeneity, which might be related to clinical outcome. Conclusion: Attention should be paid to weight loss during tomotherapy treatment and an adaptive plan should be considered to achieve prescribed doses to targets and to spare nearby critical structures if a patient shows significant weight loss.

AB - Purpose: Weight loss is a factor necessitating re‐planning to ensure that prescribed doses are delivered. Daily imaging during RT is useful to reduce uncertainties in the shapes and positions of tumors and healthy tissues. We studied the main characteristics of weight‐loss induced dose changes during tomotherapy treatment, based on an analysis of dose‐volume histograms. Method and Materials: Four head‐and‐neck cancer patients were scanned in a supine position and a target contour was delineated for each patient using a tomotherapy treatment planning system. To quantify weight‐loss induced dose changes, thermoluminescent dosimeter (TLD) measurements were also performed under conditions of changing bolus thickness, which were considered to simulate weight loss. Results: The results showed that weight loss results not only in target dose reductions but also affects tumor hot spots. Although the average minimum dose to the gross tumor volume in the four patients decreased from 91.9% to 86.7% of the prescription dose, the average maximum dose increased from 109.0% to 112.4% of the prescription dose. This suggests that weight loss‐induced cold spots and hot spots may result in significant dose inhomogeneity, which might be related to clinical outcome. Conclusion: Attention should be paid to weight loss during tomotherapy treatment and an adaptive plan should be considered to achieve prescribed doses to targets and to spare nearby critical structures if a patient shows significant weight loss.

UR - http://www.scopus.com/inward/record.url?scp=85024826629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024826629&partnerID=8YFLogxK

U2 - 10.1118/1.3182111

DO - 10.1118/1.3182111

M3 - Article

VL - 36

SP - 2665

EP - 2666

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -